Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_568AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with PKA catalytic subunit siRNA and scramble siRNA (siPKA-1)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay10 PFU/cell62% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANANANA27374176
OV_569AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with PKA catalytic subunit siRNA and scramble siRNA (siPKA-2)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay10 PFU/cell57% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANANANA27374176
OV_570AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with PKA catalytic subunit siRNA and scramble siRNA (siPKA-3)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay10 PFU/cell65% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANANANA27374176
OV_571AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay10 PFU/cell50% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_572AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.001 PFU/cell70% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_573AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.001 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_574AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.01 PFU/cell39% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_575AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.01 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_576AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.1 PFU/cell22% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_577AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.1 PFU/cell92% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_578AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay1 PFU/cell20% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_579AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay1 PFU/cell80% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_580AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell20% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_581AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay10 PFU/cell75% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_582AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.001 PFU/cell86% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_583AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.001 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_584AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.01 PFU/cell80% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_585AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.01 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_586AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.1 PFU/cell70% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_587AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.1 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_588AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay1 PFU/cell38% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_589AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay1 PFU/cell90% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_590AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell25% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_591AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay10 PFU/cell80% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_592AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1001)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_593AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1002)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell70% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_594AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1003)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell90% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_595AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1001) and with H89(10 μM)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell60% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_596AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1002) and with H89(10 μM)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell45% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_597AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1003) and with H89(10 μM)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell75% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_598AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with ESI-09 and with H89(10 μM)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay0.1 PFU/cell60% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAESI-09 abrogates the activities of Caspase-3/9/8 induced by H89/M1 combination treatment.M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_599AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with ESI-09NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay0.1 PFU/cell80% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAESI-09 abrogates the activities of Caspase-3/9/8 induced by H89/M1 combination treatment.M1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_600AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with ESI-09 and with H89(10 μM)NoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellNAMTT assay0.1 PFU/cell75% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAESI-09 abrogates the activities of Caspase-3/9/8 induced by H89/M1 combination treatment.M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_601AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with ESI-09NoATCCHuman pancreatic ductal adenocarcinoma cell lineCapan-14000 cells per wellNAMTT assay0.1 PFU/cell82% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAESI-09 abrogates the activities of Caspase-3/9/8 induced by H89/M1 combination treatment.M1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_602AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89 (10 mg/kg/d), injected intraperitoneallyNoNANANANANANANANAFemale BALB/c-nu/nu mice inoculated subcutaneously with HCT-116, 5.0E+6 cells per mouse3.0E+7 PFU/dNA Reduction in tumor volume to 0.2 cubic centimeter compared to control 1cubic centimeter after 27 daysintravenouslyActivates Caspase-3NANA27374176
OV_603AlphavirusM1RNATogaviridaeNoneYesNoNoNANANANANANANANAFemale BALB/c-nu/nu mice inoculated subcutaneously with HCT-116, 5.0E+6 cells per mouse3.0E+7 PFU/dNA Reduction in tumor volume to 0.76 cubic centimeter compared to control 1cubic centimeter after 27 daysintravenouslyActivates Caspase-3 (very small)NANA27374176
OV_604AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89 (10 mg/kg/d), injected intraperitoneallyNoNANANANANANANANAFemale BALB/c-nu/nu mice inoculated subcutaneously with Capan-1, 3.0E+6 cells per mouse3.0E+7 PFU/dNA Reduction in tumor volume to 0.1 cubic centimeter compared to control 1cubic centimeter after 23 daysintravenouslyActivates Caspase-3NANA27374176
OV_605AlphavirusM1RNATogaviridaeNoneYesNoNoNANANANANANANANAFemale BALB/c-nu/nu mice inoculated subcutaneously with Capan-1, 3.0E+6 cells per mouse3.0E+7 PFU/dNA Reduction in tumor volume to 0.2 cubic centimeter compared to control 1cubic centimeter after 23 daysintravenouslyActivates Caspase-3 (very small)NANA27374176
OV_4275AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman melanoma cell lineB164000 cells per wellNAMTT assay10 pfu2.19 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4276AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3B4000 cells per wellNAMTT assay10 pfu3.8 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4277AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineLoVo4000 cells per wellNAMTT assay10 pfu6.9 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4278AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman bladder squamous cell carcinoma cell lineSCaBER4000 cells per wellNAMTT assay10 pfu11.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4279AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman cervix carcinomaC33A4000 cells per wellNAMTT assay10 pfu14.8 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4280AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman bladder transitional cell carcinomaT244000 cells per wellNAMTT assay10 pfu21.1 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4281AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman nasopharyngeal carcinomaCNE-24000 cells per wellNAMTT assay10 pfu24.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4282AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman breast carcinoma4T14000 cells per wellNAMTT assay10 pfu26.27 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4283AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman glioblastomaC64000 cells per wellNAMTT assay10 pfu31.4 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4284AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman glioblastomaU-87 MG4000 cells per wellNAMTT assay10 pfu32.4 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4285AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman glioblastomaU2514000 cells per wellNAMTT assay10 pfu34.7 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4286AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal adenocarcinomaHCT-84000 cells per wellNAMTT assay10 pfu35.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4287AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman glioblastoma multiformeT98G4000 cells per wellNAMTT assay10 pfu38.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4288AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman prostate carcinoma22Rv14000 cells per wellNAMTT assay10 pfu39.1 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4289AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman bladder transitional cell carcinomaUM-UC-34000 cells per wellNAMTT assay10 pfu39.8 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4290AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman glioblastomaU-138 MG4000 cells per wellNAMTT assay10 pfu40.1 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4291AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal adenocarcinomaSW6204000 cells per wellNAMTT assay10 pfu43.7 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4292AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman breast carcinomaMDA-MB-4684000 cells per wellNAMTT assay10 pfu43.7 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4293AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreas epithelioid carcinomaSW19904000 cells per wellNAMTT assay10 pfu45.6 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4294AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman skin malignant melanomaA3754000 cells per wellNAMTT assay10 pfu47.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4295AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman nasopharyngeal carcinomaCNE-14000 cells per wellNAMTT assay10 pfu48.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4296AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreas carcinomaMIAPaCa-24000 cells per wellNAMTT assay10 pfu49.1 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4297AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreas epithelioid carcinomaPANC-14000 cells per wellNAMTT assay10 pfu49.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4298AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman bladder carcinoma56374000 cells per wellNAMTT assay10 pfu50.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4299AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman hepatocellular carcinomaHuh-74000 cells per wellNAMTT assay10 pfu52.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4300AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal adenocarcinomaSW4804000 cells per wellNAMTT assay10 pfu53.8 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4301AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman breast adenocarcinomaMDA-MB-2314000 cells per wellNAMTT assay10 pfu58.9 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4302AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman hepatoblastomaHuh-64000 cells per wellNAMTT assay10 pfu59 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4303AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman gliomaMGR24000 cells per wellNAMTT assay10 pfu63.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4304AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman cervix adenocarcinomaHeLa4000 cells per wellNAMTT assay10 pfu66 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4305AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman lung carcinomaA5494000 cells per wellNAMTT assay10 pfu68.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4306AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman liver adenocarcinomaSK-HEP-14000 cells per wellNAMTT assay10 pfu71.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4307AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman hepatomaLi-74000 cells per wellNAMTT assay10 pfu72.1 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4308AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman prostate adenocarcinomaPC-34000 cells per wellNAMTT assay10 pfu72.7 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4309AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman gastric carcinomaNCI-N874000 cells per wellNAMTT assay10 pfu76.4 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4310AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman nasopharyngeal carcinomaHNE-14000 cells per wellNAMTT assay10 pfu76.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4311AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman gastric carcinomaHGC-274000 cells per wellNAMTT assay10 pfu79.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4312AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman hepatomaPLC4000 cells per wellNAMTT assay10 pfu80.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4313AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay10 pfu81.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4314AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman glioblastomaDBTRG-05MG4000 cells per wellNAMTT assay10 pfu83.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4315AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreas adenocarcinomaCapan-14000 cells per wellNAMTT assay10 pfu85.1 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4316AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman acute promyelocytic leukemiaHL-604000 cells per wellNAMTT assay10 pfu85.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4317AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman mammary ductal carcinomaT-47D4000 cells per wellNAMTT assay10 pfu86.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4318AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman nonsmall cell lung cancerNCI-H3584000 cells per wellNAMTT assay10 pfu87.8 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4319AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman hepatocellular carcinomaHepG24000 cells per wellNAMTT assay10 pfu88.6 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4320AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman breast adenocarcinomaSK-BR-34000 cells per wellNAMTT assay10 pfu89.6 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4321AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman prostate carcinomaDu1454000 cells per wellNAMTT assay10 pfu91.4 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4322AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman gastric adenocarcinomaAGS4000 cells per wellNAMTT assay10 pfu92.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4323AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman glioblastomaLN-184000 cells per wellNAMTT assay10 pfu92.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4324AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman breast adenocarcinomaMCF-74000 cells per wellNAMTT assay10 pfu95.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4325AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman bladder transitional cell carcinomaEJ4000 cells per wellNAMTT assay10 pfu95.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4326AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman nonsmall cell lung cancerH-12994000 cells per wellNAMTT assay10 pfu96.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4327AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman bladder transitional cell carcinomaJ824000 cells per wellNAMTT assay10 pfu96.8 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4328AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman glioblastomaLN-2294000 cells per wellNAMTT assay10 pfu98.6 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4329AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman glioblastomaA-1724000 cells per wellNAMTT assay10 pfu98.7 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4330AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreas adenocarcinomaBxPC-34000 cells per wellNAMTT assay10 pfu98.8 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4331AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman large cell lung cancerNCI-H4604000 cells per wellNAMTT assay10 pfu99.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4332AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman cervix squamous cell carcinomaSiHa4000 cells per wellNAMTT assay10 pfu99.6 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4333AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman urinary bladder cancer cell lineT244000 cells per wellNAMTT assay0.001 MOI90% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4334AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman urinary bladder cancer cell lineT244000 cells per wellNAMTT assay0.01 MOI80% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4335AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman urinary bladder cancer cell lineT244000 cells per wellNAMTT assay0.1 MOI50% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4336AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman urinary bladder cancer cell lineT244000 cells per wellNAMTT assay10 MOI38% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347